Media stories about Arcadia Biosciences (NASDAQ:RKDA) have been trending positive this week, Accern Sentiment reports. Accern scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Arcadia Biosciences earned a media sentiment score of 0.28 on Accern’s scale. Accern also gave news stories about the basic materials company an impact score of 45.2741025580668 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Arcadia Biosciences (NASDAQ RKDA) remained flat at $$0.28 on Tuesday. The stock had a trading volume of 134,836 shares, compared to its average volume of 470,835. The company has a current ratio of 6.95, a quick ratio of 6.91 and a debt-to-equity ratio of 1.43. Arcadia Biosciences has a 12-month low of $0.26 and a 12-month high of $1.50.

Arcadia Biosciences (NASDAQ:RKDA) last released its quarterly earnings results on Thursday, August 10th. The basic materials company reported ($0.09) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.11) by $0.02. The business had revenue of $0.99 million for the quarter. Arcadia Biosciences had a negative return on equity of 87.43% and a negative net margin of 499.59%. research analysts forecast that Arcadia Biosciences will post -0.36 EPS for the current fiscal year.

Separately, Piper Jaffray Companies set a $1.00 price target on Arcadia Biosciences and gave the stock a “hold” rating in a report on Saturday, July 22nd.

COPYRIGHT VIOLATION NOTICE: “Arcadia Biosciences (RKDA) Receiving Positive Media Coverage, Analysis Finds” was first posted by Watch List News and is owned by of Watch List News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. and international trademark and copyright law. The legal version of this piece of content can be viewed at

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc is an agricultural biotechnology trait company. The Company develops a portfolio of yield and traits addressing multiple crops that supply the global food and feed markets. It has a pipeline of products in development incorporating its traits, including products that are in advanced stages of development or on the market.

Insider Buying and Selling by Quarter for Arcadia Biosciences (NASDAQ:RKDA)

Receive News & Ratings for Arcadia Biosciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.